3 Top Industrial Stocks to Watch in October
These potential outperformers are worth keeping an eye on this month.
Editors' Picks
3 Stocks Poised for Huge Growth Over the Next Decade
Looking for stocks for the long term? You might want to consider buying this artificial intelligence stock, diabetes stock, and dividend-paying utility stock.
It's on Like Donkey Kong: The Marijuana Price Wars Have Begun in Canada
One major cannabis producer aims to take on the black market with a new line of value-priced pot.
Netflix Isn't Worried About Intensifying Competition
Management has been preparing for "streaming wars" since 2012.
Recent articles
Better Buy: Magellan Midstream Partners vs. Enterprise Products Partners
Are you conservative or are you really conservative? Picking one of these two midstream income stocks is actually a tough call.
LM Ericsson Took a Big Hit From the DOJ and SEC in the Third Quarter
That's the end of an expensive business ethics investigation that started way back in 2013.
Bed Bath & Beyond's New CEO May Not Be Able to Fix the Struggling Retailer
New CEO Mark Tritton may be able to improve Bed Bath & Beyond's product assortment -- but that probably won't be enough to spur a Target-like rejuvenation for the struggling home-goods chain.
Is E-Cig Health Crisis Causing Users to Start Smoking Again?
The drumbeat of negative news may cause cigarettes to actually seem like the safer alternative.
Better Buy: Boeing vs. Airbus
Let's compare the risk and reward profiles of these two aviation giants.
Can I Contribute to an HSA if I'm on Medicare?
You can't fund an HSA if you're enrolled in Medicare, but that doesn't mean you can't use an existing one once your Medicare coverage begins.
5 Reasons the Marijuana Black Market Won't Go Away
Illicit pot production continues to dominate legal weed sales, even with Canada and select states legalizing cannabis.
RBC: Microsoft's Cloud Segment Is Crushing It
Azure and Office 365 are a powerful combination.
BridgeBio Calls Off Its Acquisition Offer for Eidos Therapeutics
BridgeBio announced this week that it had terminated its effort to acquire the remaining stake in subsidiary Eidos Therapeutics. What does this mean for Eidos shareholders?
iRobot Earnings Preview: 3 Numbers to Follow
Can this struggling stock get back on track next week?
Kratos Can Still Fly Higher After Drone Mishap
The company's most promising aircraft suffers a rough landing, but it doesn't crash the bull case for Kratos.
Is Goodyear Ready to Hit the Accelerator?
The tire giant is cutting costs, enjoying the tailwind of lower oil prices, and preparing to capitalize on its strengths.
1 Big Reason Apple May Not Be a Long-Term Lock for Your Retirement Portfolio
The tech powerhouse has tons of cash, pays a safe dividend, and has a strong business, but there are potential storm clouds off in the distance.
3 Unknown but Amazing Dividend Stocks
These Canadian oil companies have done an excellent job of rewarding their investors over the years.
3 Tax Mistakes That Could Ruin Your Retirement
Not accounting for taxes in retirement could spell trouble.
The Next iPhone Supercycle May Have Finally Arrived
Strong iPhone 11 sales and a new low-priced phone could set a new unit sales record.
Apple's iPhone 11 Could Help Drive a China Comeback
Wedbush is bullish on iPhone demand in China following channel checks.
5 Financial Moves to Make When You're Young
It pays to check these items off your list as soon as you can.
Space Tourism Price War Begins Before First Flight
And it already looks like Blue Origin is losing.
Are Your 2020 Social Security Taxes Going Up?
Find out whether you'll pay almost $300 more to Social Security next year.